Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles

Cancer Research

Volumn 58, Issue 21, 1998, Pages 4766-4770

  Plank, Tracey L ^a   Yeung, Raymond S ^b   Henske, Elizabeth Petri ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HAMARTIN; TUBERIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL CULTURE; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; MEMBRANE VESICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RAT; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL LINE; CELL MEMBRANE; CYTOPLASM; HUMANS; MICROSCOPY, CONFOCAL; MOLECULAR WEIGHT; PRECIPITIN TESTS; PROTEINS; RABBITS; RATS; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 0032213545     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Gomez, M. Phenotypes of the tuberous sclerosis complex with revision of diagnostic criteria. Ann. N. Y. Acad. Sci., 615: 1-7, 1991.
2. Roach, E., Smith, M., Huttenlocher, P., Bhat, M., Alcorn, D., and Hawley, L. Diagnostic criteria: tuberous sclerosis complex. J. Child Neurol., 7: 221-224, 1992.
3. van Slegtenhorst, M., de Hoogt, R., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., van den Ouweland, A., Halley, D., Young, J., Burley, M., Jeremiah, S., Woodward, K., Nahmias, J., Fox, M., Ekong, R., Osborne, J., Wolfe, J., Povey, S., Snell, R., Cheadle, J., Jones, A., Tachataki, M., Ravine, D., Sampson, J., Reeve, M., Richardson, P., Wilmer, R., Munro, C., Hawkins, T., Sepp, T., Ali, J., Ward, S., Green, A., Yates, J., Kwiatkowska, J., Henske, E., Short, M., Haines, J., Jozwiak, S., and Kwiatkowski, D. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science (Washington DC), 277: 805-808, 1997.
4. European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell, 75: 1305-1315, 1993.
5. Carbonara, C., Longa, L., Grosso, E., Borrone, C., Garre, M., Brisigotti, M., and Bigone, N. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum. Mol. Genet., 3: 1829-1832, 1994.
6. Green, A., Smith, M., and Yates, J. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat. Genet., 6: 193-196, 1994.
7. Green, A., Johnson, P., and Yates, J. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum. Mol. Genet., 3: 1833-1834, 1994.
8. Henske, E., Scheithauer, B., Short, M., Wollmann, R., Nahmias, J., Hornigold, N., van Slegtenhorst, M., Welsh, C., and Kwiatkowski, D. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am. J. Hum. Genet., 59: 400-406, 1996.
9. Geist, R., and Gutmann, D. The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord. Cell Growth Differ., 6: 1477-1483, 1995.
10. Wienecke, R., Maize, J., Reed, J., deGunzburg, J., Yeung, R., and DeClue, J. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. Am. J. Pathol., 150: 43-50, 1997.
11. Wienecke, R., Konig, A., and DeClue, J. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J. Biol. Chem., 270: 16409-16414, 1995.
12. Xiao, G., Shoarinejad, F., Jin, F., Golemis, E., and Yeung, R. The tuberous sclerosis-2 gene product, tuberin, functions as a Rab5GAP in modulating endocytosis. J. Biol. Chem., 272: 6097-6100, 1997.
13. Wienecke, R., Maize, J., Shoarinejad, F., Vass, W., Reed, J., Bonifacino, J., Resau, J., DeGunzburg, J., Yeung, R., and DeClue, J. Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. Oncogene, 13: 913-923, 1996.
14. van Slegtenhorst, M., Nellist, M., Nagelkerken, B., Cheadle, J., Snell, R., van den Ouweland, A., Reuser, A., Sampson, J., Halley, D., and van der Sluijs, P. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum. Mol. Genet., 7: 1053-1057, 1998.
15. Stenmark, G., Vitale, G., Ullrich, O., and Zerial, M. Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic membrane fusion. Cell, 83: 423-432, 1995.
16. Soucek, T., Pusch, O., Wienecke, R., DeClue, J., and Hengstschlager, M. Role of the tuberous sclerosis gene-2 product in cell cycle control. J. Biol. Chem., 272: 29301-29308, 1997.
17. Henry, K., Yuan, X., Koszewski, N., Ondo, H., Kwiatkowski, D., and Noonan, D. Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members. J. Biol. Chem., 273: 20535-20539, 1998.
18. Kobayashi, R., Hirayama, Y., Kobayashi, E., Kubo, Y., and Hino, O. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat. Genet., 9: 70-74, 1995.
19. Yeung, R., Xiao, G-H., Jin, F., Lee, W-C., Testa, J., and Knudson, A. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis (TSC2) gene. Proc. Natl. Acad. Sci. USA, 97: 11413-11416, 1994.
20. Xiao, G., Jin, F., and Yeung, R. Germ-line TSC2 mutation in a dominantly inherited cancer model defines a novel family of rat intracistemal-A particle elements. Oncogene, 11: 81-87, 1995.
21. Bacchi, C., Bonetti, F., Pea, M., Martignoni, G., and Gown, A. HMB-45: a review. Appl. Immunohistochem., 4: 73-85, 1996.